Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell lymphoma.
CAS Number:
[1422527-84-1]
Target:
MOR00208 , Tafasitamab-cxix , XmAb5574
* VAT and and shipping costs not included. Errors and price changes excepted